Platelet rich plasma for primary macular hole: A case series

Guglielmo Parisi,Francesco Gelormini,Federico Ricardi,Enrico Borrelli,Francesca Parisi,Giuseppe Belluardo,Laura Azzaro,Paola Marolo,Sergio D'antico,Marika Salafia,Michele Reibaldi,Sergio D’antico
DOI: https://doi.org/10.1177/11206721241234419
2024-03-03
European Journal of Ophthalmology
Abstract:European Journal of Ophthalmology, Ahead of Print. ObjectiveTo evaluate the anatomical and functional macular results and rate of complications following surgical treatment of primary macular hole (MH) with autologous platelet rich plasma (a-PRP) use.Designretrospective, interventional, non-randomized case seriesPartecipants and methodsA cohort of 9 consecutive patients from January 1, 2019 to August 31, 2021 who underwent vitrectomy with a-PRP use for primary MH were included. Anatomical results based on spectral domain- optical coherence tomography (SD-OCT) and visual acuity were analyzed.Results10 pseudophakic eye of 9 patients were enrolled. Six patients were female and three patients were male. The mean age was 69.9 years ± 1.48. The baseline MH minimum diameter was 486.1 μm ± 37.1, and mean pre operative best-corrected visual acuity (BCVA) was 0.91 ± 0.03 logMAR (Snellen equivalent 20/160). Mean 1 month post operative BCVA was 0.81 ± 0.57 logMAR (Snellen equivalent 20/130; p = 1.000); mean 3 month post operative BCVA was 0.66 ± 0.04 logMAR (Snellen equivalent 20/90; p = 0.006); mean 6 month post operative BCVA was 0.6 ± 0.04 logMAR (Snellen equivalent 20/80; p < 0.001). In all eyes, 10/10 (100%), there was a complete MH closure at 6 months follow up: 5 eyes (50%) with a U-type closure pattern, 4 eyes (40%) with a V-type pattern and 1 eye (10%) with an irregular foveal contour closure at 6 month follow-up. No ocular and systemic complications were reported.ConclusionThe a-PRP use is a successful and promising vitreoretinal surgical technique option for primary MH
ophthalmology
What problem does this paper attempt to address?